Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Nov;12(5):667-73.
doi: 10.1111/j.1365-2125.1981.tb01287.x.

Ethanol 'dose-dependent' elimination: Michaelis-Menten v classical kinetic analysis

Ethanol 'dose-dependent' elimination: Michaelis-Menten v classical kinetic analysis

R E Rangno et al. Br J Clin Pharmacol. 1981 Nov.

Abstract

1 To compare classical linear regression techniques and a Michaelis-Menten elimination model eight normal human volunteers each received three intravenous doses (0.375, 0.5, and 0.75 g/kg) of ethanol and four of the subjects each received four oral doses (0.5, 0.65, 0.95, 1.25 g/kg) of ethanol. 2 Computerized analysis of the time-plasma concentration profiles using a two-compartment Michaelis-Menton elimination model yielded a median absorption constant of 1.29 h-1; volume of distribution of 0.47 l/kg; Vmax of 0.12 g h-1 kg-1; and Km of 0.03 g/l. Classical techniques resulted in a slope of 0.20 g l-1 h-1, volume of distribution of 0.55 l/kg, and a B60 of 0.11 g h-1 kg-1. 3 Transient post-prandial decreases in elimination slope occurred at higher oral doses. A trend of increasing slope with increasing oral dose was seen at concentrations well above the Km. Time to sobriety (0.8 g/l) increased nonlinearly with increasing peak concentration. 4 Maximal ethanol elimination rates are determined equally well by the two techniques. Classical analyses overestimate the volume of distribution of ethanol by 17%. Neither technique helps explain the post-prandial changes in slope or increasing slope with dose at high concentrations.

PubMed Disclaimer

References

    1. Nature. 1968 Mar 9;217(5132):963-4 - PubMed
    1. Clin Pharmacol Ther. 1971 Mar-Apr;12(2):192-201 - PubMed
    1. Biochem Pharmacol. 1973 May 15;22(10):1133-40 - PubMed
    1. J Pharmacokinet Biopharm. 1973 Apr;1(2):103-21 - PubMed
    1. J Pharm Sci. 1976 Jan;65(1):152-4 - PubMed

LinkOut - more resources